
Keywords: Ucn 1; urocortin; CRF; corticotropin releasing hormone; CRF-R; corticotropin releasing hormone receptor; PD; Parkinson's disease; SN; substantia nigra; GSK-3β; glycogen synthase kinase- 3β; HDAC; histone deacetylase; RA; rheumatoid arthritis; OA; osteoa